Rumour has it: It takes 10-15 years to bring a new therapy to the patients. Only 1% of all scientific ideas make it to the market - is another statistical fact.
How do those people who made developing novel therapies their mission make money on their way?
In this episode, I have the huge pleasure to chat with Thomas Schirrmann. He has profound experience in starting companies from scratch, walking through the ups and downs of Death Valley, and turn it into a commercial success.
Listen to his insights in creating and developing life science companies.
Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Thomas Schirrmann (https://www.linkedin.com/in/thomas-schirrmann-45a64183/)
Companies:
Corat Therapeutics (https://www.linkedin.com/company/corat-therapeutics/)
CS Life Science Invest (https://www.cslifescienceinvest.com)
Yumab (https://www.linkedin.com/company/yumab-gmbh/)
Do you want to learn more about life science?
Subscribe to our newsletter: https://mailchi.mp/e2467061ef75/lsg2g
Explore strategies to thrive financially, build legacy, and enhance life experiences.
Listen on: Apple Podcasts Spotify
Buzzsprout - Let's get your podcast launched!Start for FREE
The LSG2G Partners
Experts in Life Science
Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.
Join the Podcast Newsletter: Link
Popular Podcasts
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
Death, Sex & Money
Anna Sale explores the big questions and hard choices that are often left out of polite conversation.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.